Site-directed mutagenesis is a widely used technique in molecular biology to generate single or multiple exchanges, insertions or deletions in DNA sequences. A number of strategies have been developed and used successfully (2, 4) . The QuikChange ™Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) has proven valuable because it consistently yields high mutagenesis efficiencies and uses a rapid and simple protocol. The high-fidelityPfuDNA polymerase (Stratagene) is used for PCR from a supercoiled plasmid template with two complementary mutagenesis oligonucleotide primers that minimize undesirable random mutations during PCR (8, 9) . Treatment of the DNA with restriction enzyme Dpn I, which will cut only fully or hemimethylated 5 ′ -G m6 ATC-3 ′ sequences in duplex DNA, leads to the selective digestion of the PCR template DNA (5, 9) .
The in vitro synthesized unmethylated DNA, including the introduced base change(s), is resistant to Dpn I digestion and used to transfect Escherichia coli competent cells. Because this preselection step eliminates the parental DNA, the ratio of mutation-harboring recombinant clones reaches levels above 95% for 2.9 kb templates and more than 83% for templates of 8 kb length (6) . However, for the introduction of more than one point mutation at different sites, timeconsuming intermittent transformation and screening steps are required before the DNA template is available for a second round of PCR mutagenesis. Furthermore, it is often necessary to sequence the isolated recombinant clones to identify single base changes. This step substantially increases the time between consecutive rounds of mutagenesis.
Since the introduction of the QuikChange site-directed mutagenesis method (6) , variations of the basic protocol have been presented, including a procedure for simultaneous two-site mutagenesis using the megaprimer protocol (3). Here, we present a procedure based on the QuikChange mutagenesis system that allows the introduction of multiple mutations with high efficiency. By using in vitro dam-methylation between successive PCR amplifications, only a single transformation and DNA preparation step after the introduction of all mutations is required. A substantial amount of time is saved while still preserving high targeting efficiency.
The β -galactosidase ( lacZ ) α -fragment gene from pUC19 (New England Biolabs, Beverly, MA, USA) carrying two or three point mutations (introduced by two or three sets of mutagenesis primers) was used as the template in our experiments to determine the mutagenesis efficiencies with our protocol. The construct harboring two mutations has a one-nucleotide insertion at a Hin dIII restriction site and a one-nucleotide substitution at a Pvu II site. The template is referred to as pHmPm. The DNA construct with three point mutations carries an additional two-nucleotide deletion at an Eco RI site and is referred to as pEmHmPm. The corresponding oligonucleotide primer sets used for single-step mutagenesis were:
All mutations generate premature stop codons, which gives rise to a truncated lacZα -fragment that is not functional in complementation. To generate revertants from the mutant templates, two (pHmPm) or three (pEmHmPm) sets of primers were used for PCR with PfuDNA polymerase. The respective reversion PCR primers were:
These primers were phosphorylated at their 5 ′ end with T4 polynucleotide kinase (New England Biolabs) as described (7) . For all plasmid DNA preparations and transformations, we used the E. coli strain Epicurian Coli ® SURE ® (Stratagene). Figure 1 shows an overview of the protocol. The first PCR mutagenesis reaction with the pHmPm and pEmHmPm mutant templates was performed in a reaction volume of 50 µ L that included 100 ng of template DNA, 150 ng (ca. 15 pmoles) of each primer, 200 µ M dNTPs and 2.5 U of native PfuDNA polymerase in 1 ×Pfupolymerase reaction buffer as provided by the supplier. For PCR mutagenesis, a total of 15 cycles were run with 30 s denaturation at 95°C, 1 min annealing at 55°C and 5 min 30 s extension at 68°C using the GeneAmp ® PCR Thermocycler System 9600 (PE Biosystems, Foster City, CA, USA). After restriction enzyme digestion with 10 U of Dpn I for 1 h at 37°C, the DNA was electrophoresed in a 1.2% agarose gel to separate Dpn I-resistant DNA.
Using a QIAex ® II Gel Extraction Kit (Qiagen, Valencia, CA, USA), intact-size, undigested DNA was recovered from agarose gel slices. The isolated DNA was then incubated with 400 U of T4 DNA ligase, 10 U of T4 polynucleotide kinase and 10 U of E. coli dam-methylase in 1 ×T4 DNA ligase buffer supplemented with 400 nM Sadenosylmethionine (all from New England Biolabs) for 1 h at 37°C in a total volume of 60 µ L. The processed DNA was cleaned with the QIAquick ™ PCR purification kit (Qiagen) and eluted with 55 µ L of distilled water. Twenty microliters of the eluted DNA were used as the template for the next PCR with the second set of mutagenesis primers under the same conditions as in the primary PCR. The Dpn I-digested DNA from the final PCR (second round for pHmPm, third for pEmHmPm) was directly used for transformation of competent E. coli cells by the Ca 2+ -coprecipitation technique (1). Figure 2 shows in comparison the Dpn I-treated PCR products after each amplification during the three-site mutagenesis. Blue-white colony selection with LB agar plates containing 40 µ g/mL X-gal and 100 µ g/mL ampicillin was performed to screen for revertants with lacZα -fragments active in complementation. The mutagenesis efficiencies were determined as the ratio of blue colonies compared to the total number of ampicillin-resistant bacterial clones. At least 500 individual colonies from each transformation were counted.
The targeting efficiencies obtained for the two-site mutagenesis (89.0% ± 1.1%) and three-site mutagenesis (83.8% ±0.2%) using our protocol demonstrate that even after two rounds of in vitro dam-methylation and ligation, no substantial drop in targeting efficiency was observed. All mutagenesis experiments were performed in triplicate, confirming the reproducibility of our results. Compared to the basic QuikChange mutagenesis protocol, our procedure saves at least 1.5 days when introducing two independent mutations. Less than 4 h are needed between each PCR amplification step for Dpn I digestion, DNA isolation and dammethylation/ligation.
The relative time advantage, with respect to the basic QuikChange protocol and the megaprimer protocol (if more than two independent positions are to be targeted), increases further as more mutations are introduced. If the number of desired point mutations is large, then we recommend including a transformation and selection step after 4-6 rounds of in vitro methylation/ligation to preserve high mutagenesis efficiency, especially when large DNA templates (>5 kb) are involved. Our protocol may also prove valuable when intermittent phenotypic selection is unfavorable because the involved sequences affect bacterial growth behavior (due to expression of the gene) or the targeted gene is unstable or prone to recombination events in vivo, which significantly reduces targeting efficiencies. The implementation of targeted modifications in genomes through homologous recombination has become an important and widely used genetic tool. In the case of bacteria, a number of strategies introduce short deletions and insertions, or even entire foreign genes or operons in the chromosome of a given host.
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A popular strategy relies on the use of narrow host range plasmids to force the chromosomal recombination of foreign genes in bacteria in which the plasmid is unable to replicate. A second recombination event that leads to the loss of vector sequences is subsequently selected for by the use of the plasmid-encoded sac B gene of Bacillus subtilis . This gene confers sucrose sensitivity to the host cells (12-16) or the rpsLgene from Escherichia coli , which confers streptomycin sensitivity to streptomycin-resistant cells (18,19). However, these approaches are not suitable for bacteria in which the plasmid can replicate. To circumvent this problem, conditional replication "suicide" plasmids are used. For example, plasmid pMAK700 expresses a thermosensitive replication initiation protein (repAts) derived from ts mutants of plasmid pSC101, such that replication from its origin occurs at 30°C but not at 42°C (5) . In another design, plasmids pJM703 (11) and pKNG101 (6) are driven by the conditional origin of replication of the R6K plasmid ( oriR6K ), which is only functional in the presence of the π protein coded by the pir gene.
Under nonpermissive conditions for replication (growth at 42°C for pMAK700, absence of the pir gene for pJM703 and pKNG101), the selection for a plasmid-borne marker (e.g., an antibiotic resistance gene) will only allow 
